Page last updated: 2024-08-23

mefloquine and saquinavir

mefloquine has been researched along with saquinavir in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Back, DJ; Bray, PG; Chandler, B; Hart, CA; Hartkoorn, RC; Janneh, O; Khoo, SH; Martin, P; Owen, A; Ward, SA	1
Andrews, KT; Gardiner, DL; McCarthy, J; Melville, L; Skinner-Adams, TS	1

Reviews

2 review(s) available for mefloquine and saquinavir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Other Studies

2 other study(ies) available for mefloquine and saquinavir

Article	Year
In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:3 Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Protein Binding; RNA, Messenger; Saquinavir; U937 Cells	2005
Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Animals; Antimalarials; Chloroquine; Drug Synergism; HIV Protease Inhibitors; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Ritonavir; Saquinavir	2007

Article

Year

In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine.

The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:3

Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Protein Binding; RNA, Messenger; Saquinavir; U937 Cells

2005

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

Topics: Animals; Antimalarials; Chloroquine; Drug Synergism; HIV Protease Inhibitors; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Ritonavir; Saquinavir

2007